KMDA Q2 2025 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$45M+5.4% YoY

Gross Profit

$19M42.3% margin

Operating Income

$7M15.8% margin

Net Income

$7M16.5% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$6M

Stock-Based Comp.

$95,000

Balance Sheet

Total Assets

$368M

Total Liabilities

$108M

Stockholders' Equity

$260M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$42M	+5.4%
Gross Profit	$19M	$19M	-0.1%
Operating Income	$7M	$6M	+25.4%
Net Income	$7M	$4M	+66.7%